Nasdaq

Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined ...

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and ...
BioWorld

Myriad study shows discrepancies in Clinvar database for hereditary cancer classification

Public genetic databases could have a discrepancy in identifying BRCA1 and BRCA2 variant classifications, which can introduce uncertainty and diminish patient care, according to a study by Myriad ...
Reuters

Atara Bio receives ATMP classification for its EBV-CTLs product candidate from EMA

* Atara Bio receives advanced therapy medicinal product classification for allogeneic epstein-barr virus specific cytotoxic T-Lymphocytes (EBV-CTLs) from European Medicines Agency (EMA) Source text ...
Reuters

Mustang Bio Receives Advanced Therapy Medicinal Product Classification For Mb-107 Lentiviral Gene Therapy

* MUSTANG BIO RECEIVES ADVANCED THERAPY MEDICINAL PRODUCT CLASSIFICATION FROM EUROPEAN MEDICINES AGENCY FOR MB-107 LENTIVIRAL GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY Source text for ...
BioTechniques

Incucyte® advanced label-free classification

This Protocol provides a working example of label-free quantification of live and dead cells utilizing the Incucyte® Live-cell Analysis System and the Incucyte® Advanced Label-free software module.